Skip to main content
. 2021 Jul 23;70:103485. doi: 10.1016/j.ebiom.2021.103485

Table 2.

Results of the main and secondary/sensitivity analyses.

N cases N controls Odds Ratio (95%CI) P-value
Composite outcome
LTL (age-adjusted) (per 1 SD shorter) 914 5861 1·17 (1·05, 1·30) 0·004
Age at COVID-19 test (per 5 yrs older) 1·58 (1·51, 1·65) <0·001
Sex (male vs female) 1·88 (1·62, 2·19) <0·001
Ethnicity (non-White vs White) 1·80 (1·39, 2·34) <0·001
Separate components as outcome*
Hospitalisation 672 5861 1·17 (1·03, 1·32) 0·013
Critical care support 383 1·31 (1·12, 1·53) <0·001
Respiratory support 279 1·36 (1·13, 1·64) <0·001
Death 157 1·36 (1·07, 1·72) 0·013
Population controls
LTL (age-adjusted) (per 1 SD shorter) 914 465,946 1·19 (1·08, 1·31) <0·001
Excluding participants with recent hospitalisation
LTL (age-adjusted) (per 1 SD shorter) 732 5861 1·15 (1·02, 1·30) 0·019
Mendelian Randomisation
MR IVW 914 5861 1·30 (0·85, 2·00) 0·224
MR-median 1·25 (0·62, 2·50) 0·537

The main analysis is based on our composite outcome and the full multivariable model estimates are shown for each risk factor. *For each component of the composite outcome analysed separately, the results shown for these are labelled by outcome component but represent the LTL (age-adjusted) estimate (per 1 SD shorter). For each analysis, the numbers of cases and controls are given alongside the odds ratio, 95% confidence interval and P-value (from logistic regression models or MR). MR IVW: Mendelian randomisation inverse-variance weighted method. MR-median: Mendelian randomisation weighted median method.